#Inhalational Anaesthetic Agents

> <p style="color:purple";> Describe the effects of inhalational agents on the cardiovascular, respiratory and central nervous systems</p>

<!--></!-->

> <p style="color:purple";> Describe the toxicity of inhalational agents </p>

<!--></!-->

> <p style="color:purple";> Describe the comparative pharmacology of ~~nitrous oxide~~, halothane, enflurane, isoflurane, desflurane, sevoflurane, xenon and ether</p>

##Common Features of Inhalation Agents

|Property|Action|
|--|--|
|**Resp**|All halogenated agents ↓ V<sub>T</sub> and ↑ RR, with an overall ↓ in MV and therefore cause PaCO<sub>2</sub> to ↑; and ↓ sensitivity of central respiratory centres to CO<sub>2</sub>.
|**CVS**|↓ MAP (predominantly by ↓ in SVR), ↓ inotropy
|**CNS**|↓ EEG frequency such that θ- and δ-wave dominate the EEG as depth ↑. May cause burst suppression. ↓ CMRO<sub>2</sub> and CBF. Cause cerebral vasodilation but **do not increase ICP** when MAC is < 1.
|**GIT**|↓ hepatic blood flow. 
|**GU**|Tocolysis
|**Immune**|
|**Metabolic**|
|**Toxic Effects**|

##Comparison of Common Inhalation Agents
|Property|Sevoflurane|Isoflurane|Desflurane|Nitrous Oxide|
|--|--|
|**Pharmaceutics**|Minimally soluble, light stable, not flammable|Soluble in rubber, light stable, not flammable|Light sensitive, flammable at 17%|Non-flammable
|**Molecular Weight**|
|**Boiling point**|||23.5°C|-88°C
|**Critical Temperature/Pressure**||||36.5°C / 72 bar
|**SVP**|||
|**Blood:gas coefficient**|0.7|1.4||0.47
|**Oil:gas coefficient**|53|98|19|1.4
|**MAC**|2|1.17|6.6|105
|**Metabolism**|3-5% hepatic metabolism|0.2% hepatic to nontoxic metabolites
|**Resp**|Bronchodilation|Bronchodilation, airway irritability|Airway irritability, ↑ secretions|Hypoxia due to second gas effect.
|**CVS**|↑ QT|More proarrhythmic (than sevoflurane or desflurane)
|**CNS**||||Analgesic via endorphin and encephalin modulation, and on opioid receptors.
|**GIT**||||N/V
|**Immune**|
|**Metabolic**|
|**Toxic Effects**|Sevoflurane interacts with soda lime to produce **Compound A**, which is nephrotoxic in rats (but not, it seems, in humans).|May react with soda lime to produce CO||High diffusing capacity means it will rapidly diffuse into air-filled cavities, increasing the volume of compliant cavities (PTHx, bowel), and increasing the pressure of non-compliant cavities (middle ear). <br><br> Inhibits **methionine synthetase**, which can cause demyelination in the dorsal columns (acutely) and the spinal cord (subacutely in the setting of B<sub>12</sub> deficiency. <br><br> Potentially teratogenic - avoid in early pregnancy. <br><br> Greenhouse gas.

##Comparison of Uncommon Inhalational Agents
|Property|Methoxyflurane|Enflurane|Halothane|Ether|Xenon|
|--|--|
|**Pharmaceutics**|||||Not flammable
|**Molecular Weight**|
|**Boiling point**|
|**SVP**|||
|**Blood:gas coefficient**|||||0.14
|**Oil:gas coefficient**||98|224||1.9
|**MAC**||1.68|0.75||71
|**Metabolism**|||~25% undergoes oxidative phosphorylation by CYP450 systems, producing **trifluoroacetic acid**, which binds to protein and can cause a T-cell mediated hepatitis, which can be fatal in ~1/10,000 anaesthetics.
|**Resp**|
|**CVS**|
|**CNS**|||||Analgesic|
|**MSK**|||||Muscle relaxation when >60%
|**Renal**|Direct nephrotoxicity, potentially related to fluoride (though this association is not present with other anaesthetic agents)


↓ HR, ↑

##References
Pharmacology of anaesthetic agents II: inhalation anaesthetic agents
Petkov
Peck and Hill
Dr. Podcast
Millers



